24 May 2013
Keywords: thrombogenics, moves, up, belgium, midcap, index, nv
Article | 29 September 2008
ThromboGenics NV, now trading on the Euronext Brussels, has announced its promotion to the Belgian Midcap index (Bel Mid Index). ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2008
© 2013 thepharmaletter.com